Abiopharma

New Form 8-K - Odyssey Health, Inc. Filed: 2025-08-04 AccNo: 0001683168-25-005637 Size: 200 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

New Form 4 - STRYKER CORP Filed: 2025-08-04 AccNo: 0000310764-25-000110 Size: 5 KB

New Form 144 - STEPAN CO Filed: 2025-08-04 AccNo: 0002007317-25-000796 Size: 4 KB

New Form 4 - AMARIN CORP PLC\UK Filed: 2025-08-04 AccNo: 0000950170-25-102119 Size: 9 KB

New Form 4 - ORASURE TECHNOLOGIES INC Filed: 2025-08-04 AccNo: 0001062993-25-013517 Size: 4 KB

New Form 10-Q - GLAUKOS Corp Filed: 2025-08-04 AccNo: 0001558370-25-010113 Size: 9 MB

New Form 144 - FATE THERAPEUTICS INC Filed: 2025-08-04 AccNo: 0001959173-25-004933 Size: 4 KB

New Form SCHEDULE 13D/A - Mallinckrodt plc Filed: 2025-08-04 AccNo: 0000899140-25-000860 Size: 11 KB

New Form 144 - CHEMED CORP Filed: 2025-08-04 AccNo: 0001969223-25-000557 Size: 10 KB

New Form 8-K - EXICURE, INC. Filed: 2025-08-04 AccNo: 0001698530-25-000071 Size: 153 KB Item 8.01: Other Events

New Form 4 - Editas Medicine, Inc. Filed: 2025-08-04 AccNo: 0001650664-25-000113 Size: 4 KB

New Form 4 - RxSight, Inc. Filed: 2025-08-04 AccNo: 0000950170-25-102098 Size: 5 KB

New Form 3 - RxSight, Inc. Filed: 2025-08-04 AccNo: 0000950170-25-102093 Size: 14 KB

New Form 4 - Mallinckrodt plc Filed: 2025-08-04 AccNo: 0001641172-25-022063 Size: 12 KB

New Form 4 - Gevo, Inc. Filed: 2025-08-04 AccNo: 0001415889-25-020970 Size: 6 KB